Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Schizoaffective and Schizophreniform Disorders”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Post-approval studies (Phase 4)Study completedNCT00391261
What this trial is testing

An Open-label Trial of Metformin for Weight Control of Pediatric Patients on Antipsychotic Medications.

Who this might be right for
SchizophreniaSchizoaffective DisorderSchizophreniform Disorder+2 more
Cambridge Health Alliance 11
Large-scale testing (Phase 3)Study completedNCT00145444
What this trial is testing

Kahn Study; Investigation Of The Efficacy Of Ziprasidone Versus Olanzapine In The Management Of Recent-Onset Psychosis; A Flexible-Dose, Parallel Group, Double-Blind Study

Who this might be right for
SchizophreniaPsychotic Disorders
Pfizer's Upjohn has merged with Mylan to form Viatris Inc. 100
Not applicableStudy completedNCT00222495
What this trial is testing

A Comparative Study of New Medications for Psychosis in Adolescents

Who this might be right for
Psychotic DisordersSchizophreniaSchizophreniform Disorders+1 more
University of Minnesota 30
Not applicableStudy completedNCT01321177
What this trial is testing

An Integrated Program for the Treatment of First Episode of Psychosis

Who this might be right for
SchizophreniaSchizoaffective DisorderSchizophreniform Disorder+2 more
Northwell Health 404
Not applicableStudy completedNCT01866098
What this trial is testing

Naltrexone for Antipsychotic-Induced Weight Gain

Who this might be right for
SchizophreniaSchizoaffective DisorderSchizophreniform Disorder+2 more
Yale University 144
Large-scale testing (Phase 3)Study completedNCT01999309
What this trial is testing

Simvastatin Addition for Patients With Recent-onset Schizophrenia

Who this might be right for
SchizophreniaSchizoaffective DisorderSchizophreniform Disorder+1 more
Iris Sommer 121
Not applicableNot Yet RecruitingNCT05416658
What this trial is testing

Shared Decision Making for Antipsychotic Medications

Who this might be right for
SchizophreniaSchizoaffective DisorderSchizophreniform Disorders+2 more
New York State Psychiatric Institute 120
Not applicableStudy completedNCT02160249
What this trial is testing

RISE (Rehabilitation Intervention for People With Schizophrenia in Ethiopia)

Who this might be right for
Schizophrenia Spectrum DisorderSchizophreniaSchizoaffective Disorder+1 more
London School of Hygiene and Tropical Medicine 166
Post-approval studies (Phase 4)Ended earlyNCT00681629
What this trial is testing

Schizophrenic Patients in Integrated Care

Who this might be right for
SchizophreniaSchizoaffective DisorderSchizophreniform Disorder
AstraZeneca 7
Not applicableStudy completedNCT01029769
What this trial is testing

Efficacy of an Early Antipsychotic Switch in Case of Poor Initial Response to the Treatment of Schizophrenia

Who this might be right for
SchizophreniaSchizoaffective DisorderSchizophreniform Disorder
Technical University of Munich 350
Large-scale testing (Phase 3)Study completedNCT00421954
What this trial is testing

Open-label Ziprasidone Study for Psychosis Treatment in Adolescents

Who this might be right for
Schizophreniform DisorderSchizoaffective DisorderPsychosis+2 more
New York State Psychiatric Institute 8
Not applicableStudy completedNCT02600741
What this trial is testing

Family Intervention in Recent Onset Schizophrenia Treatment (FIRST)

Who this might be right for
Schizophrenia
Janssen Scientific Affairs, LLC 296
Post-approval studies (Phase 4)Study completedNCT00337662
What this trial is testing

Efficacy Study of Early Onset of Antipsychotic Drug Action in Schizophrenia

Who this might be right for
SchizophreniaSchizoaffective DisorderSchizophreniform Disorder
Eli Lilly and Company 628
Not applicableStudy completedNCT04673851
What this trial is testing

Horyzons: Implementation in Clinical Practice

Who this might be right for
SchizophreniaSchizoaffective DisorderSchizophreniform Disorders+1 more
University of North Carolina, Chapel Hill 85
Post-approval studies (Phase 4)Looking for participantsNCT05958875
What this trial is testing

The Effect of a Six Week Intensified Pharmacological Treatment for Schizophrenia Compared to Treatment as Usual in Subjects Who Had a First-time Treatment Failure on Their First-line Treatment.

Who this might be right for
Schizophrenia and Related DisordersEarly Treatment-Resistance
Dr. Inge Winter 418
Post-approval studies (Phase 4)Study completedNCT00333177
What this trial is testing

Psychosocial Therapy and Risperidone Treatment in Work Performance in Recent-Onset Schizophrenia

Who this might be right for
Schizophrenia
University of California, Los Angeles 92
Testing effectiveness (Phase 2)Study completedNCT00709202
What this trial is testing

Efficacy and Tolerability Study of Betahistine to Ameliorate Antipsychotic Associated Weight Gain

Who this might be right for
SchizophreniaSchizoaffective DisorderSchizophreniform Disorder+5 more
Nathan Kline Institute for Psychiatric Research 48
Large-scale testing (Phase 3)Study completedNCT03043820
What this trial is testing

Raloxifene Augmentation in Patients With a Schizophrenia Spectrum Disorder

Who this might be right for
SchizophreniaSchizoaffective DisorderSchizophreniform Disorder+1 more
Iris Sommer 110
Early research (Phase 1)Study completedNCT00929955
What this trial is testing

Role of Anti-Inflammatory Agents in Patients With Schizophrenia

Who this might be right for
SchizophreniaSchizoaffective DisorderPsychosis Not Otherwise Specified+1 more
Pakistan Institute of Living and Learning 36
Post-approval studies (Phase 4)Study completedNCT01339858
What this trial is testing

The Effect of N-Acetyl Cysteine on Cortical Erosion in Early Stage Schizophrenia

Who this might be right for
SchizophreniaPsychotic Disorder NOSSchizoaffective Disorder+1 more
Indiana University 60
Next Page